Synergistic photodynamic and photothermal therapy of BODIPY-conjugated hyaluronic acid nanoparticles

J Biomater Sci Polym Ed. 2021 Oct;32(15):2028-2045. doi: 10.1080/09205063.2021.1954138. Epub 2021 Jul 29.

Abstract

The combination of photodynamic therapy (PDT) and photothermal therapy (PTT) has emerged as a promising strategy for complete tumor ablation therapy. Herein, a boron dipyrromethene (BODIPY)-conjugated hyaluronic acid polymer that can self-assemble to form the nanoparticles (BODIPY-HA NPs) was prepared for combined cancer PDT and PTT. The fluorescence emission and reactive oxygen species (ROS) generation of BODIPY-HA NPs were inhibited because of the π-π stacking behavior of BODIPY, resulting in photothermal effect under 808 nm light irradiation. Upon the internalization by cancer cells, the BODIPY-HA NPs could disassemble into BODIPY-HA molecules, with the recovery of the fluorescence and ROS generation for PDT. Importantly, in vitro results confirmed that combined PTT and PDT have exhibited better anticancer effect than PTT alone upon 808 nm laser irradiation. These results showed that the self-assembled BODIPY-HA NPs may be a promising nanomedicine for synergistic cancer PDT and PTT.

Keywords: BODIPY; hyaluronic acid; photodynamic therapy; photothermal therapy; synergistic effect.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Boron
  • Cell Line, Tumor
  • Hyaluronic Acid
  • Nanoparticles*
  • Photochemotherapy*
  • Photothermal Therapy
  • Porphobilinogen / analogs & derivatives

Substances

  • dipyrromethene
  • Porphobilinogen
  • Hyaluronic Acid
  • Boron